CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $kalv--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced it will be presenting at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, 2022 at 3:00 p.m. ET. A live webcast of the presentation will be available on the Company’s website at An audio [...]